Johnson & Johnson

Top Stories

Johnson & Johnson, Drug Distributors Finalize $26 Billion Opioid Settlement

While the COVID-19 Pandemic Has Been Dominating the Headlines for the Last Few Years, There’s Another Long-Standing Public Health Crisis…

Read More »
Top Stories

Capitalist Countdown: Wealthy VC’s Top 5 Investing News Stories of the Week

Welcome to the Capitalist Countdown By Wealthy VC The Capitalist Countdown is a weekly series that features the biggest stories…

Read More »
Biotech

Johnson & Johnson Kicks Off Big Pharma’s Q3 Earnings SZN

Johnson & Johnson (NYSE: JNJ) reported its Q3 2021 earnings on October 19th and beat EPS estimates by nearly 10%.…

Read More »
Biotech

Investors Shift Focus From Vaccine Stocks to COVID Pill Stocks

Nearly two years since the COVID-19 pandemic began and almost one year since the various COVID-19 vaccines started to roll…

Read More »
Top Stories

Capitalist Countdown: Wealthy VC’s Top 10 Investing News Stories of the Week

Unlike the many other mundane weekly news recaps, the team at Wealthy VC has made it its mission to scour…

Read More »
Back to top button